- New iron chelators in anthracycline-induced cardiotoxicity2007 | Publication without faculty affiliation
- Heart failure model induced by the repeated administration of anthracyclines in rabbitsPublication without faculty affiliation
- Anthracyclines in the palliative treatment of breast cancer2011 | First Faculty of Medicine
- Problem of early detection of anthracycline cardiomyopathy in experimental in vivo modelPublication without faculty affiliation
- Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance2016 | Faculty of Pharmacy in Hradec Králové
- Anthracyclines in the treatment of generalized breast cancer2011 | First Faculty of Medicine
- Assessment of anthracycline-induced cardiotoxicity with electrocardiography2009 | First Faculty of Medicine
- Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity +1Publication without faculty affiliation
- Electrocardiographic changes in association with anthracycline treatment in acute leukemia2006 | Publication without faculty affiliation
- Electrocardiographic changes in association with anthracycline treatment in acute leukemia2006 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Electrocardiographic changes in association with anthracycline treatment in acute leukemia +12006 | First Faculty of Medicine
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Central Library of Charles University
- Assessment of anthracycline-induced cardiotoxicity with biochemical markers2007 | First Faculty of Medicine
- Assessment of acute and chronic cardiac toxicity of anthracyclines with electrocardiography +12007 | Faculty of Medicine in Hradec Králové
- Assessment of acute and chronic cardiac toxicity of anthracyclines with electrocardiography2007 | First Faculty of Medicine
- Continuous 24-hours monitoring of electrocardiogram during anthracycline-based therapy2008 | Faculty of Medicine in Hradec Králové
- Continuous 24-hours monitoring of electrocardiogram during anthracycline-based therapy2008 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Proteomic insights into chronic anthracycline cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | Faculty of Medicine in Hradec Králové
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | First Faculty of Medicine
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Faculty of Medicine in Hradec Králové
- Anthracycline cardiotoxicity - mechanisms of development and pharmacological cardioprotectionPublication without faculty affiliation
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity2008 | First Faculty of Medicine
- Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status2014 | Faculty of Medicine in Hradec Králové
- Diagnostic window of cardiac troponin T on model of anthracycline-induced cardiomyopathy2016 | Faculty of Medicine in Hradec Králové
- Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia2009 | First Faculty of Medicine